Assessment and monitoring of biologic drug adverse events in patients with psoriasis

Assessment and monitoring of biologic drug adverse events in patients with psoriasis

Tessa Hanley, Marc Handford, Dawn Lavery, Zenas ZN Yiu Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester, UKBackground: Current treatment guidelines for biologic therapies in psoriasis differ in their recommendation for the monitoring of adverse events.Objective: The aim of this pap...

Full description

Bibliographic Details
Main Authors: Hanley T, Handford M, Lavery D, Yiu ZZN
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:Psoriasis : Targets and Therapy
Subjects:
Biologics
monitoring
psoriasis
screening
safety
Online Access:https://www.dovepress.com/assessment-and-monitoring-of-biologic-drug-adverse-events-in-patients--peer-reviewed-article-PTT

Internet

https://www.dovepress.com/assessment-and-monitoring-of-biologic-drug-adverse-events-in-patients--peer-reviewed-article-PTT

Similar Items